Form 8-K - Current report:
SEC Accession No. 0001104659-14-067329
Filing Date
2014-09-19
Accepted
2014-09-19 17:26:15
Documents
2
Period of Report
2014-09-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-17237_58k.htm 8-K 19253
2 EX-99.1 a14-17237_5ex99d1.htm EX-99.1 9499
  Complete submission text file 0001104659-14-067329.txt   30064
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 141112707
SIC: 2834 Pharmaceutical Preparations